BDNF DNA methylation changes as a biomarker of psychiatric disorders: Literature review and open access database analysis

Behavioral and Brain Functions

Volumn 12, Issue 1, 2016, Pages

  Zheleznyakova, Galina Y ^a,b   Cao, Hao ^a   Schiöth, Helgi B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BDNF; Biomarkers; DNA methylation; Psychiatric disorders

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BIOLOGICAL MARKER; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ACCESS TO INFORMATION; BDNF GENE; CPG ISLAND; DATA BASE; DISEASE ASSOCIATION; DISEASE MARKER; DNA DETERMINATION; DNA METHYLATION; DNA MODIFICATION; GENE EXPRESSION; GENETIC ASSOCIATION; MAJOR DEPRESSION; MENTAL DISEASE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SCHIZOPHRENIA; ANIMAL; BLOOD; BRAIN; GENETIC DATABASE; GENETICS; HUMAN; METABOLISM; PHENOTYPE;

ANIMALS; BIOMARKERS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DATABASES, GENETIC; DNA METHYLATION; HUMANS; MENTAL DISORDERS; PHENOTYPE; PROMOTER REGIONS, GENETIC;

EID: 84986905088     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/s12993-016-0101-4     Document Type: Review

References (71)

1. Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol. 2001;63(1):71-124.
2. Pruunsild P, et al. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics. 2007;90(3):397-406.
3. Boulle F, et al. Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry. 2012;17(6):584-96.
4. Mitchelmore C, Gede L. Brain derived neurotrophic factor: epigenetic regulation in psychiatric disorders. Brain Res. 2014;1586:162-72.
5. Tsankova NM, et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci. 2006;9(4):519-25.
6. Jha S, et al. Enriched environment treatment reverses depression-like behavior and restores reduced hippocampal neurogenesis and protein levels of brain-derived neurotrophic factor in mice lacking its expression through promoter IV. Transl Psychiatry. 2011;1:e40. doi: 10.1038/tp.2011.33.
7. Lee Y, et al. Association between the BDNF Val66Met polymorphism and chronicity of depression. Psychiatry Investig. 2013;10(1):56-61.
8. Brooks SJ, et al. BDNF polymorphisms are linked to poorer working memory performance, reduced cerebellar and hippocampal volumes and differences in prefrontal cortex in a Swedish elderly population. PLoS ONE. 2014;9(1):e82707. doi: 10.1371/journal.pone.0082707.
9. Notaras M, et al. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review. Neurosci Biobehav Rev. 2015;51:15-30.
10. Sarchiapone M, et al. Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology. 2008;57(3):139-45.
11. Rosenfeld RD, et al. Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr Purif. 1995;6(4):465-71.
12. Kerschensteiner M, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med. 1999;189(5):865-70.
13. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;37(12):1553-61.
14. Molendijk ML, et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry. 2011;16(11):1088-95.
15. Nurjono M, et al. A review of brain-derived neurotrophic factor as a candidate biomarker in Schizophrenia. Clin Psychopharmacol Neurosci. 2012;10(2):61-70.
16. Suliman S, et al. Brain-derived neurotrophic factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front Integr Neurosci. 2013;7:55.
17. Koenigsberg HW, et al. Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients. Psychiatry Res. 2012;199(2):92-7.
18. Wolkowitz OM, et al. Serum BDNF levels before treatment predict SSRI response in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(7):1623-30.
19. Guintivano J, Kaminsky ZA. Role of epigenetic factors in the development of mental illness throughout life. Neurosci Res. 2016;102:56-66.
20. Pishva E, et al. The epigenome and postnatal environmental influences in psychotic disorders. Soc Psychiatry Psychiatr Epidemiol. 2014;49(3):337-48.
21. Varendi K, et al. miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF. Cell Mol Life Sci CMLS. 2014;71(22):4443-56.
22. Ikegame T, et al. DNA methylation of the BDNF gene and its relevance to psychiatric disorders. J Hum Genet. 2013;58(7):434-8.
23. Martinowich K, et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science. 2003;302(5646):890-3.
24. Vialou V, et al. Epigenetic mechanisms of depression and antidepressant action. Annu Rev Pharmacol Toxicol. 2013;53:59-87.
25. Egger G, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429(6990):457-63.
26. Allis CD, Jenuwein T, Reinberg D. Epigenetics. CSHL Press; 2007
27. Illingworth RS, Bird AP. CpG islands-'a rough guide'. FEBS Lett. 2009;583(11):1713-20.
28. Weber M, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet. 2007;39(4):457-66.
29. Zhang Y, et al. DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution. PLoS Genet. 2009;5(3):e1000438. doi: 10.1371/journal.pgen.1000438.
30. Spruijt CG, Vermeulen M. DNA methylation: old dog, new tricks? Nat Struct Mol Biol. 2014;21(11):949-54.
31. Ball MP, et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol. 2009;27(4):361-8.
32. Maunakea AK, et al. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res. 2013;23(11):1256-69.
33. Choi JK, et al. Nucleosome deposition and DNA methylation at coding region boundaries. Genome Biol. 2009;10(9):R89. doi: 10.1186/gb-2009-10-9-r89.
34. Schübeler D. Epigenetic Islands in a genetic ocean. Science. 2012;338(6108):756-7.
35. Tufarelli C, et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet. 2003;34(2):157-65.
36. Lehnertz B, et al. Suv39 h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol CB. 2003;13(14):1192-200.
37. Davies MN, et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 2012;13(6):R43. doi: 10.1186/gb-2012-13-6-r43.
38. Spiers H, et al. Methylomic trajectories across human fetal brain development. Genome Res. 2015;25:338. doi: 10.1101/gr.180273.114.
39. Masliah E, et al. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics. 2013;8(10):1030-8.
40. Wen L, et al. Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain. Genome Biol. 2014;15(3):R49. doi: 10.1186/gb-2014-15-3-r49.
41. Pruunsild P, et al. Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene. J Neurosci. 2011;31(9):3295-308.
42. Roth TL, et al. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry. 2009;65(9):760-9.
43. Roth TL, Sweatt JD. Epigenetic marking of the BDNF gene by early-life adverse experiences. Horm Behav. 2011;59(3):315-20.
44. Mill J, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet. 2008;82(3):696-711.
45. Chagnon YC, et al. DNA methylation and single nucleotide variants in the brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) genes are associated with anxiety/depression in older women. Genet Aging. 2015;6:230.
46. Keller S, et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry. 2010;67(3):258-67.
47. Fuchikami M, et al. DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS ONE. 2011;6(8):e23881. doi: 10.1371/journal.pone.0023881.
48. Kang H-J, et al. BDNF promoter methylation and suicidal behavior in depressive patients. J Affect Disord. 2013;151(2):679-85.
49. Kang HJ, et al. Longitudinal associations between BDNF promoter methylation and late-life depression. Neurobiol Aging. 2015;36(4):1764. doi: 10.1016/j.neurobiolaging.2014.12.035.
50. Kang H-J, et al. A longitudinal study of BDNF promoter methylation and depression in breast cancer. Psychiatry Investig. 2015;12(4):523-31.
51. Kleimann A, et al. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy. J Neural Transm. 2014;122(6):925-8.
52. Ikegame T, et al. DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients. Neurosci Res. 2013;77(4):208-14.
53. Kordi-Tamandani DM, et al. DNA methylation and expression profiles of the brain-derived neurotrophic factor (BDNF) and dopamine transporter (DAT1) genes in patients with schizophrenia. Mol Biol Rep. 2012;39(12):10889-93.
54. D'Addario C, et al. Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacol. 2012;37(7):1647-55.
55. D'Addario C, et al. Epigenetic modulation of BDNF gene in patients with major depressive disorder. Biol Psychiatry. 2013;73(2):e6-7. doi: 10.1016/j.biopsych.2012.07.009.
56. Dell'Osso B, et al. Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients. J Affect Disord. 2014;166:330-3.
57. Tadić A, et al. Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. Mol Psychiatry. 2014;19(3):281-3.
58. Perroud N, et al. Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene. Transl Psychiatry. 2013;3:e207. doi: 10.1038/tp.2012.140.
59. Unternaehrer E, et al. Childhood maternal care is associated with DNA methylation of the genes for brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) in peripheral blood cells in adult men and women. Stress. 2015;18(4):451-61.
60. Thaler L, et al. Methylation of BDNF in women with bulimic eating syndromes: associations with childhood abuse and borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:43-9.
61. Mikeska T, Craig JM. DNA methylation biomarkers: cancer and beyond. Genes. 2014;5(3):821-64.
62. Stenz L, et al. BDNF promoter I methylation correlates between post-mortem human peripheral and brain tissues. Neurosci Res. 2015;91:1-7.
63. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res. 2007;35(6):e41. doi: 10.1093/nar/gkm013.
64. Shen L, Waterland RA. Methods of DNA methylation analysis. Curr Opin Clin Nutr Metab Care. 2007;10(5):576-81.
65. Lewin J, et al. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics. 2004;20(17):3005-12.
66. Uhlmann K, et al. Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis. Electrophoresis. 2002;23(24):4072-9.
67. Milutinovic S, et al. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis. 2007;28(3):560-71.
68. Deltheil T, et al. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology. 2008;55(6):1006-14.
69. Berton O, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311(5762):864-8.
70. Reinius LE, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS ONE. 2012;7(7):e41361. doi: 10.1371/journal.pone.0041361.
71. Maes M, et al. Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med. 1992;22(1):45-53.